Atlas Trials

Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine

Clinical trial NCT05835635 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05835635
Sponsor
Pontificia Universidad Catolica de Chile
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Patient SatisfactionPatient PreferenceQuality of LifeAcceptability of Health Care
Start date
2025-05-01
Primary completion
2025-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.